
  
    
      
        Introduction_NNP
        Progression_NNP through_IN the_DT mammalian_JJ cell_NN cycle_NN requires_VBZ
        that_DT gene_NN expression_NN is_VBZ coordinated_VBN with_IN the_DT activity_NN of_IN
        cell_NN cycle_NN control_NN proteins_NNS ._. A_DT critical_JJ period_NN is_VBZ the_DT
        transition_NN from_IN the_DT G_NNP 1_CD into_IN the_DT S_NNP phase_NN ,_, as_IN cells_NNS become_VBP
        committed_VBN to_TO the_DT division_NN cycle_NN ._. Binding_NNP of_IN free_JJ E_NNP 2_CD F_NN /_NN DP_NNP
        heterodimers_NNS to_TO E_NNP 2_CD F_NN sites_NNS generally_RB activates_NNS transcription_NN
        of_IN proteins_NNS required_VBN for_IN G_NNP 1_CD →_NN S_NNP transition_NN and_CC DNA_NNP
        synthesis_NN [_NN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD ]_NN ,_, whereas_IN complex_JJ formation_NN with_IN
        pRb_NN or_CC other_JJ pocket_NN proteins_NNS including_VBG p_NN 107_CD and_CC pRb-_NN 2_CD /_NN p_NN 130_CD
        silences_NNS transcriptional_NN activities_NNS of_IN downstream_JJ target_NN
        genes_NNS [_NN 6_CD ,_, 7_CD ,_, 8_CD ,_, 9_CD ,_, 10_CD ]_NN ._. The_DT resulting_VBG retinoblastoma_NN
        protein_NN (_( Rb_NNP )_) -_: E_NNP 2_CD F_NN interaction_NN not_RB only_RB blocks_VBZ
        transcriptional_NN activation_NN by_IN E_NNP 2_CD F_NN ,_, but_CC also_RB forms_VBZ an_DT active_JJ
        transcriptional_NN repressor_NN complex_JJ at_IN the_DT promoter_NN of_IN cell_NN
        cycle_NN genes_NNS that_WDT can_MD block_VB transcription_NN by_IN recruiting_VBG
        histone_NN deacetylase_NN (_( HDAC_NNP )_) and_CC remodeling_VBG chromatin_NN [_NN 11_CD ,_,
        12_CD ,_, 13_CD ,_, 14_CD ]_NN ._.
        Several_JJ HDAC_NNP inhibitors_NNS mediate_VB cell_NN growth_NN arrest_NN
        and_CC /_NN or_CC differentiation_NN [_NN 15_CD ,_, 16_CD ,_, 17_CD ]_NN ._. We_PRP chose_VBD to_TO examine_VB
        the_DT effect_NN of_IN HPCs_NNP ,_, which_WDT have_VBP been_VBN reported_VBN to_TO induce_VB
        terminal_NN differentiation_NN and_CC /_NN or_CC apoptosis_NNS [_NN 18_CD ,_, 19_CD ,_, 20_CD ]_NN in_IN
        many_JJ transformed_VBN cells_NNS ._. Although_IN treatment_NN with_IN HMBA_NNP
        induces_VBZ remission_NN in_IN patients_NNS with_IN myelodysplastic_JJ syndrome_NN
        and_CC acute_JJ myelogenoud_NN leukemia_NN ,_, it_PRP is_VBZ not_RB currently_RB used_VBN
        therapeutically_RB because_IN of_IN the_DT high_JJ dosage_NN required_VBN
        (_( millimolar_NN blood_NN levels_NNS )_) and_CC the_DT accompanying_VBG toxic_JJ side_NN
        effects_NNS (_( thrombocytopenia_NN )_) [_NN 21_CD ]_NN ._.
        In_IN this_DT study_NN ,_, we_PRP report_VBP a_DT novel_NN mechanism_NN of_IN cell_NN
        growth_NN inhibition_NN by_IN the_DT second_JJ generation_NN of_IN HPCs_NNP ,_, named_VBD
        SAHA_NNP ,_, which_WDT is_VBZ 2000_CD -_: fold_VB more_RBR potent_JJ than_IN HMBA_NNP and_CC bears_VBZ at_IN
        least_JJS one_CD hydroxamide_NN in_IN place_NN of_IN the_DT amides_NNS in_IN HMBA_NNP [_NN 17_CD ]_NN ._.
        SAHA_NNP was_VBD reported_VBN to_TO be_VB a_DT histone_NN deacetylase_NN inhibitor_NN and_CC
        caused_VBN accumulation_NN of_IN hyperacetylated_JJ histone_NN H_NNP 4_CD in_IN murine_NN
        erythroleukemia_NN [_NN 17_CD ]_NN ._. Very_RB little_JJ is_VBZ known_VBN about_IN the_DT
        anticancer_NN mechanism_NN of_IN SAHA_NNP in_IN epithelial_NN cells_NNS ;_: however_RB ,_,
        a_DT recent_JJ study_NN demonstrated_VBN that_IN SAHA_NNP diet_NN ,_, at_IN 900_CD parts_NNS
        per_IN million_CD (_( ppm_NN )_) ,_, fed_VBN to_TO rats_NNS reduced_VBD
        methylenitrosouren-induced_JJ mammary_JJ tumor_NN incidence_NN by_IN 40_CD %_NN ,_,
        total_JJ tumors_NNS by_IN 66_CD %_NN and_CC tumor_NN volume_NN by_IN 78_CD %_NN [_NN 22_CD ]_NN ._. In_IN this_DT
        study_NN ,_, we_PRP tested_VBD whether_IN SAHA_NNP has_VBZ similar_JJ potency_NN to_TO
        inhibit_VB cell_NN growth_NN in_IN two_CD mouse_NN mammary_JJ epithelial_NN cell_NN
        lines_NNS ,_, TM_NNP 10_CD (_( p_NN 53_CD wt_NN )_) and_CC TM_NNP 2_CD H_NNP (_( p_NN 53_CD null_NN )_) ._. We_PRP identified_VBD a_DT
        novel_NN mechanism_NN for_IN SAHA_NNP in_IN cell_NN growth_NN arrest_NN through_IN
        inhibition_NN in_IN DNA_NNP synthesis_NN ,_, concomitant_NN with_IN significant_JJ
        increases_NNS in_IN the_DT nuclear_JJ localization_NN of_IN pRb-_NN 2_CD /_NN p_NN 130_CD
        associated_VBN with_IN E_NNP 2_CD F-_NNP 4_CD ,_, decreases_NNS in_IN key_JJ molecules_NNS in_IN DNA_NNP
        synthesis_NN (_( E_NNP 2_CD F-_NNP 1_CD ,_, PCNA_NNP and_CC p_NN 21_CD )_) ,_, and_CC increases_NNS in_IN histone_NN
        H_NNP 3_CD and_CC H_NNP 4_CD protein_NN and_CC acetylation_NN levels_NNS ._. This_DT study_NN
        discusses_NNS the_DT difference_NN in_IN recovery_NN from_IN cell_NN growth_NN
        inhibition_NN in_IN two_CD mammary_JJ epithelial_NN cell_NN lines_NNS ,_, TM_NNP 10_CD and_CC
        TM_NNP 2_CD H_NNP ,_, after_IN SAHA_NNP removal_NN from_IN cultures_NNS ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Development_NNP of_IN cell_NN lines_NNS and_CC cell_NN culture_NN
          The_DT TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN lines_NNS chosen_VBN for_IN this_DT study_NN
          were_VBD isolated_VBN from_IN two_CD different_JJ mouse_NN mammary_JJ
          hyperplastic_JJ outgrowths_NNS :_: TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP ,_, respectively_RB ,_, as_IN
          described_VBN earlier_JJR [_NN 23_CD ]_NN ._. The_DT parental_JJ TM_NNP 10_CD outgrowth_NN is_VBZ a_DT
          moderately_RB tumorigenic_JJ outgrowth_NN line_NN 
          in_IN vivo_NN (_( time_NN for_IN 50_CD %_NN of_IN the_DT
          transplants_NNS to_TO produce_VB tumors_NNS ,_, 11_CD months_NNS )_) that_WDT is_VBZ
          karyotypically_RB diploid_NN and_CC maintains_VBZ wild_JJ type_NN p_NN 53_CD
          expression_NN ._. TM_NNP 2_CD H_NNP ,_, in_IN contrast_NN ,_, is_VBZ a_DT highly_RB tumorigenic_JJ
          outgrowth_NN line_NN 
          in_IN vivo_NN (_( time_NN for_IN 50_CD %_NN of_IN the_DT
          transplants_NNS to_TO produce_VB tumors_NNS ,_, ≤_NN 4_CD months_NNS )_) ,_,
          karyotypically_RB aneuploid_NN (_( DNA_NNP index_NN =_SYM 1_CD ._. 69_CD )_) and_CC contains_VBZ
          a_DT p_NN 53_CD mutation_NN resulting_VBG in_IN a_DT null_NN phenotype_NN [_NN 24_CD ]_NN ._.
          Exponentially_NNP growing_VBG TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN lines_NNS in_IN
          DMEM_NNP /_NN F_NN 12_CD media_NNS buffered_JJ with_IN 10_CD mM_NN HEPES_NNP at_IN pH_NN 7_CD ._. 6_CD with_IN
          2_CD %_NN adult_NN bovine_JJ serum_NN ,_, 10_CD μg_NN /_NN ml_NN insulin_NN ,_, 5_CD ng_NN /_NN ml_NN
          epidermal_NN growth_NN factor_NN (_( EGF_NNP )_) and_CC 5_CD μg_NN /_NN ml_NN gentamycin_NN at_IN
          60_CD -_: 70_CD %_NN confluence_NN were_VBD treated_VBN with_IN SAHA_NNP (_( courtesy_NN of_IN Dr_NNP
          Paul_NNP Marks_NNP and_CC Dr_NNP Victoria_NNP Richon_NNP ,_, Memorial_NNP Sloan_NNP
          Kettering_NNP Cancer_NNP Center_NNP ,_, New_NNP York_NNP ,_, NY_NNP ,_, USA_NNP )_) ._. Cells_NNP were_VBD
          examined_VBN at_IN the_DT time_NN points_NNS indicated_VBD for_IN cell_NN growth_NN and_CC
          cell_NN cycle_NN activities_NNS ._.
        
        
          Analysis_NNP of_IN cell_NN growth_NN
          Cell_NNP growth_NN rates_NNS of_IN TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP lines_NNS were_VBD
          determined_VBN using_VBG a_DT [_NN 3_CD H_NNP ]_NN -_: thymidine_NN uptake_NN assay_NN ,_, as_IN
          described_VBN earlier_JJR [_NN 25_CD ]_NN ._. In_IN initial_JJ studies_NNS ,_, both_DT cell_NN
          lines_NNS were_VBD cultured_JJ in_IN the_DT absence_NN or_CC presence_NN of_IN 0_CD ._. 1_CD ,_,
          2_CD ._. 5_CD ,_, 5_CD ._. 0_CD ,_, and_CC 10_CD μM_NN SAHA_NNP for_IN 6_CD days_NNS ._. Both_DT cell_NN lines_NNS were_VBD
          also_RB cultured_JJ for_IN 2_CD days_NNS in_IN the_DT presence_NN of_IN SAHA_NNP at_IN the_DT
          concentrations_NNS already_RB mentioned_VBN ,_, followed_VBN by_IN removing_VBG
          SAHA_NNP from_IN the_DT media_NNS for_IN a_DT subsequent_JJ 4_CD days_NNS ._. Based_VBN on_IN the_DT
          results_NNS of_IN these_DT studies_NNS ,_, subsequent_JJ experiments_NNS examined_VBD
          asynchronously_RB growing_VBG TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN lines_NNS in_IN the_DT
          presence_NN or_CC absence_NN of_IN 2_CD ._. 5_CD μM_NN SAHA_NNP for_IN 24_CD h_NN ._.
        
        
          FACS_NNP analysis_NN
          Exponentially_NNP growing_VBG cells_NNS at_IN 60_CD -_: 70_CD %_NN confluence_NN at_IN
          control_NN or_CC treated_VBN with_IN 2_CD ._. 5_CD μM_NN SAHA_NNP for_IN 24_CD h_NN were_VBD
          pulse-labeled_JJ for_IN 1_CD h_NN with_IN 10_CD μM_NN BrdU_NNP (_( Sigma_NNP ,_, St_NNP Louis_NNP ,_,
          MO_NNP ,_, USA_NNP )_) ._. The_DT cell_NN cultures_NNS were_VBD rinsed_JJ once_RB with_IN
          phosphate_NN buffered_JJ saline_NN (_( PBS_NNP )_) ,_, trypsinized_JJ for_IN 3_CD min_NN
          and_CC rinsed_JJ three_CD times_NNS with_IN PBS_NNP ._. Cells_NNP were_VBD resuspended_JJ
          in_IN 200_CD μl_NN PBS_NNP and_CC fixed_VBN in_IN 5_CD ml_NN cold_JJ 70_CD %_NN ethanol_NN
          overnight_JJ ._. Fixed_NNP cells_NNS were_VBD counted_VBN and_CC ,_, generally_RB ,_, 4_CD ×_NN
          10_CD 6_CD cells_NNS were_VBD transferred_VBN to_TO 15_CD ml_NN polypropylene_NN tubes_NNS ,_,
          centrifuged_JJ at_IN 3000_CD rpm_NN for_IN 5_CD min_NN and_CC the_DT supernatant_NN
          removed_VBN ._. Cells_NNP were_VBD stained_JJ for_IN the_DT newly_RB incorporated_VBN
          BrdU_NNP for_IN DNA_NNP synthesis_NN using_VBG BrdU_NNP monoclonal_NN antibodies_NNS
          conjugated_JJ to_TO fluorescein_NN isothiocyanate_NN (_( FITC_NNP )_) and_CC
          stained_JJ with_IN propidium_NN iodide_NN for_IN DNA_NNP content_NN following_VBG
          the_DT protocol_NN described_VBD in_IN Becton_NNP and_CC Dickinson_NNP 's_POS (_( San_NNP
          Diego_NNP ,_, CA_NNP ,_, USA_NNP )_) instructions_NNS for_IN flow_NN cytometric_JJ
          analysis_NN ._.
        
        
          Nuclear_NNP and_CC cytoplasmic_JJ extracts_NNS
          To_TO obtain_VB nuclei_NN ,_, (_( 4_CD -_: 6_CD )_) ×_NN 10_CD 7_CD cells_NNS of_IN each_DT cell_NN line_NN
          grown_VBN in_IN the_DT presence_NN and_CC absence_NN of_IN 2_CD ._. 5_CD μM_NN SAHA_NNP were_VBD
          washed_VBN twice_RB in_IN PBS_NNP ,_, followed_VBN by_IN suspension_NN in_IN 0_CD ._. 3_CD ml_NN
          nuclear_JJ buffer_NN consisting_VBG of_IN 2_CD mM_NN MgCl_NNP 
          2_CD ,_, 5_CD mM_NN K_NNP 
          2_CD HPO_NNP 
          4_CD ,_, 0_CD ._. 1_CD mM_NN EDTA_NNP ,_, 1_CD mM_NN PMSF_NNP ,_, 20_CD μg_NN /_NN ml_NN
          aprotinin_NN ,_, 20_CD μg_NN /_NN ml_NN leupeptin_NN ,_, 0_CD ._. 1_CD mM_NN Na_NNP 
          3_CD VO_NNP 
          4_CD and_CC 5_CD mM_NN β-glycerophosphate_JJ ._. An_DT
          additional_JJ 0_CD ._. 3_CD ml_NN nuclear_JJ buffer_NN containing_VBG 0_CD ._. 7_CD %_NN Triton_NNP
          X-_NNP 100_CD was_VBD then_RB added_VBN ,_, after_IN standing_VBG on_IN ice_NN for_IN 8_CD -_: 10_CD min_NN ._.
          The_DT suspensions_NNS were_VBD examined_VBN for_IN cell_NN lysis_NNS
          microscopically_RB ,_, centrifuged_JJ at_IN 800_CD rpm_NN for_IN 10_CD min_NN at_IN
          4_CD °_NN C_NNP ,_, and_CC the_DT supernatant_NN designated_VBN the_DT cytoplasmic_JJ
          fraction_NN ._. The_DT pellets_NNS were_VBD washed_VBN once_RB with_IN nuclear_JJ
          buffer_NN ,_, and_CC the_DT nuclear_JJ extracts_NNS were_VBD prepared_VBN by_IN
          resuspending_VBG the_DT pellets_NNS in_IN 0_CD ._. 3_CD ml_NN buffer_NN containing_VBG 20_CD
          mM_NN HEPES_NNP (_( pH_NN 7_CD ._. 8_CD )_) ,_, 25_CD %_NN glycerol_NN ,_, 0_CD ._. 42_CD M_NNP NaCl_NNP ,_, 1_CD ._. 5_CD mM_NN MgCl_NNP
          
          2_LS ,_, 0_CD ._. 2_CD mM_NN EDTA_NNP ,_, 0_CD ._. 5_CD mM_NN PMSF_NNP ,_, 0_CD ._. 5_CD mM_NN
          DTTl_NNP ,_, 0_CD ._. 1_CD mM_NN Na_NNP 
          3_CD VO_NNP 
          4_CD ,_, 50_CD mM_NN NaF_NNP ,_, 20_CD μg_NN /_NN ml_NN leupeptin_NN ,_, and_CC
          5_CD mM_NN β-glycerophosphate_JJ ._. Sonication_NNP was_VBD carried_VBN out_IN on_IN
          ice_NN using_VBG an_DT ultrasonicator_NN processor_NN (_( PGC_NNP Scientific_NNP ,_,
          Caithersburg_NNP ,_, MA_NNP ,_, USA_NNP )_) ,_, and_CC the_DT mixtures_NNS were_VBD examined_VBN
          microscopically_RB for_IN complete_JJ break_NN of_IN the_DT nuclei_NN ._. The_DT
          supernatants_NNS were_VBD designated_VBN as_IN nuclear_JJ extracts_NNS after_IN
          centrifugation_NN of_IN the_DT mixtures_NNS ,_, and_CC the_DT total_JJ protein_NN was_VBD
          determined_VBN in_IN the_DT nuclear_JJ and_CC cytoplasmic_JJ fractions_NNS ._.
        
        
          Western_JJ blot_NN and_CC immunoprecipitation_NN
          analysis_NN
          Histones_NNP were_VBD isolated_VBN and_CC lyophilized_JJ from_IN nuclear_JJ
          extracts_NNS in_IN SAHA_NNP treated_VBD and_CC untreated_JJ TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN
          lines_NNS following_VBG a_DT protocol_NN described_VBD earlier_JJR [_NN 26_CD ]_NN ._.
          Histone_NNP samples_NNS were_VBD assessed_VBN for_IN purification_NN quality_NN on_IN
          15_CD %_NN SDS_NNP acrylamide_NN gel_NN including_VBG calf_NN thymus_JJ histones_NNS as_IN
          controls_NNS before_IN western_JJ blot_NN analysis_NN was_VBD carried_VBN out_RP ._.
          Histone_NNP samples_NNS were_VBD resolved_VBN by_IN electrophoresis_NNS using_VBG
          15_CD %_NN acid-urea_JJ gel_NN containing_VBG 36_CD %_NN w_NN /_NN v_NN urea_NN ,_, 5_CD %_NN v_NN /_NN v_NN acetic_JJ
          acid_NN ,_, 600_CD μl_NN TEMED_NNP and_CC 0_CD ._. 7_CD ml_NN of_IN 10_CD %_NN ammonium_NN persulfate_NN
          prepared_VBN as_IN described_VBN elsewhere_RB [_NN 27_CD ]_NN ._. Gels_NNP were_VBD either_CC
          stained_JJ by_IN Coomassie_NNP Brilliant_NNP Blue_NNP or_CC equilibrated_JJ to_TO be_VB
          transferred_VBN into_IN transfer_NN buffer_NN (_( 0_CD ._. 7_CD %_NN acetic_JJ acid_NN )_) ._. The_DT
          gel_NN sandwich_NN was_VBD set_VBN up_RP as_IN usual_JJ except_IN for_IN the_DT placement_NN
          of_IN the_DT blotting_VBG membrane_NN (_( because_IN proteins_NNS in_IN this_DT type_NN
          of_IN gel_NN will_MD migrate_VB toward_IN the_DT negative_JJ electrode_NN )_) ,_, and_CC
          the_DT procedure_NN was_VBD continued_VBN as_IN described_VBN earlier_JJR [_NN 27_CD ]_NN ._.
          Each_DT histone_NN was_VBD resolved_VBN into_IN multiple_JJ bands_NNS and_CC were_VBD
          visualized_JJ in_IN Coomassie_NNP blue_JJ gel_NN ._. The_DT acetylated_JJ histone_NN
          isoforms_NNS were_VBD detected_VBN by_IN immunoblot_NN against_IN acetylated_JJ
          histone_NN H_NNP 3_CD isoforms_NNS using_VBG anti-_NN H_NNP 3_CD antibodies_NNS raised_VBD and_CC
          characterized_VBN by_IN Dr_NNP Sharon_NNP Roth_NNP at_IN MD_NNP Anderson_NNP Cancer_NNP
          Center_NNP (_( personal_JJ communication_NN )_) or_CC against_IN acetylated_JJ
          histone_NN H_NNP 4_CD isoforms_NNS using_VBG anti-_NN H_NNP 4_CD polyclonal_NN antibody_NN
          (_( Upstate_NNP Biotechnology_NNP Inc_NNP ,_, Lake_NNP Placid_NNP ,_, NY_NNP ,_, USA_NNP )_) ._.
          Western_JJ blot_NN analysis_NN for_IN all_PDT the_DT proteins_NNS examined_VBD in_IN
          this_DT study_NN was_VBD carried_VBN out_IN on_IN equal_JJ amounts_NNS of_IN cellular_JJ
          fraction_NN protein_NN extracts_NNS (_( 100_CD μg_NN /_NN sample_NN )_) following_VBG a_DT
          protocol_NN described_VBD earlier_JJR [_NN 25_CD ]_NN ._. Staining_NNP the_DT gel_NN with_IN
          Coomassie_NNP Brilliant_NNP Blue_NNP for_IN each_DT experiment_NN assessed_VBD
          equal_JJ loading_NN control_NN ._. TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cells_NNS (_( 0_CD ._. 65_CD ×_NN 10_CD
          3_CD cells_NNS /_NN cm_NN 2_LS )_) seeded_VBN in_IN 75_CD T_NN flasks_NNS grew_VBD for_IN 2_CD days_NNS ,_, and_CC
          were_VBD treated_VBN with_IN 2_CD ._. 5_CD μM_NN SAHA_NNP for_IN 24_CD h_NN ._. Cellular_NNP fraction_NN
          protein_NN extracts_NNS were_VBD prepared_VBN after_IN SAHA_NNP treatment_NN [_NN
          25_CD ]_NN ._. Primary_JJ antibodies_NNS used_VBN at_IN 1_CD or_CC 2_CD μg_NN /_NN ml_NN were_VBD p_NN 21_CD /_NN Cip_NNP
          (_( Pharmingen_NNP Inc_NNP ,_, San_NNP Diego_NNP ,_, CA_NNP ,_, USA_NNP )_) ,_, pRb_NN (_( IF_IN 8_CD )_) ,_, p_NN 107_CD
          (_( SD_NNP 9_CD )_) ,_, p_NN 130_CD (_( C-_NNP 20_CD )_) ,_, E_NNP 2_CD F-_NNP 1_CD (_( C-_NNP 20_CD )_) ,_, E_NNP 2_CD F-_NNP 4_CD (_( C-_NNP 20_CD )_) and_CC PCNA_NNP
          (_( C-_NNP 20_CD )_) (_( Santa_NNP Cruz_NNP Biotechnology_NNP Inc_NNP ,_, Santa_NNP Cruz_NNP ,_, CA_NNP ,_,
          USA_NNP )_) ._. All_DT antibodies_NNS were_VBD examined_VBN for_IN specificity_NN prior_RB
          to_TO use_VB ._. The_DT secondary_JJ antibodies_NNS conjugated_JJ to_TO
          horseradish_NN peroxidase_NN (_( 1_CD :_: 5000_CD -_: 1_CD :_: 15_CD ,_, 000_CD dilution_NN )_)
          were_VBD used_VBN followed_VBN by_IN enhanced_JJ chemiluminescence_NN
          detection_NN reaction_NN as_IN described_VBN by_IN the_DT manufacturer_NN
          (_( Amersham_NNP Pharmacia_NNP Biotechnology_NNP ,_, Amersham_NNP ,_, Bucks_NNP ,_,
          UK_NNP )_) ._.
          The_DT immunoprecipitation_NN assay_NN followed_VBN by_IN western_JJ blot_NN
          analysis_NN was_VBD as_IN described_VBN previously_RB [_NN 25_CD ]_NN ._. Briefly_NNP ,_,
          equal_JJ nuclear_JJ cell_NN extract_NN (_( 200_CD μg_NN /_NN sample_NN )_) was_VBD mixed_VBN with_IN
          3_CD μg_NN anti-_NN E_NNP 2_CD F-_NNP 4_CD antibodies_NNS at_IN 4_CD °_NN C_NNP followed_VBN by_IN the_DT
          addition_NN of_IN 50_CD μl_NN protein_NN A-_NNP sepharose_NN beads_NNS (_( Amersham_NNP
          Biotechnology_NNP )_) ._. The_DT immune_JJ complex_NN was_VBD centrifuged_JJ ,_, and_CC
          the_DT proteins_NNS in_IN the_DT immune_JJ complex_NN were_VBD resolved_VBN by_IN 10_CD %_NN
          SDS-PAGE_NNP followed_VBN by_IN western_JJ blot_NN analysis_NN using_VBG
          anti-p_JJ Rb-_NNP 2_CD /_NN p_NN 130_CD antibodies_NNS as_RB already_RB described_VBD for_IN
          western_JJ blot_NN analysis_NN ._.
        
        
          Cyclin-dependent_NNP kinase_NN assay_NN
          The_DT TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN cultures_NNS at_IN control_NN and_CC treated_VBN
          with_IN 2_CD ._. 5_CD μM_NN SAHA_NNP for_IN 24_CD h_NN were_VBD examined_VBN for_IN cyclin_NN D_NNP 1_CD ,_, E_NNP ,_,
          and_CC A_DT associated_VBN kinase_NN activities_NNS as_IN described_VBN
          previously_RB [_NN 28_CD ]_NN ._. Briefly_NNP ,_, cellular_JJ protein_NN extracts_NNS (_( 25_CD
          μg_NN )_) were_VBD precleared_JJ with_IN 10_CD μl_NN of_IN 10_CD %_NN preimmune_NN normal_JJ
          rabbit_NN serum_NN followed_VBN by_IN immunoprecipitation_NN with_IN either_DT
          3_CD μg_NN anti-cyclin_JJ D_NNP 1_CD ,_, E_NNP polyclonal_NN antibodies_NNS (_( Upstate_NNP
          Biotechnology_NNP )_) ,_, 2_CD μg_NN anti-cyclin_JJ A_DT polyclonal_NN antibody_NN
          antibodies_NNS (_( C-_NNP 19_CD )_) -_: G_NNP (_( Pharmingen_NNP )_) ,_, or_CC normal_JJ rabbit_NN
          preimmune_NN serum_NN as_IN a_DT negative_JJ control_NN ._. All_DT antibodies_NNS
          were_VBD examined_VBN for_IN specificity_NN [_NN 28_CD ]_NN ._. Immunoprecipitate_NNP
          complexes_NNS were_VBD examined_VBN for_IN kinase_NN assay_NN following_VBG a_DT
          procedure_NN described_VBD previously_RB [_NN 28_CD ]_NN ._. The_DT substrates_NNS
          utilized_JJ in_IN the_DT kinase_NN assays_NNS were_VBD either_CC Histone-_NNP H_NNP 1_CD
          (_( Sigma_NNP )_) or_CC RB_NNP protein_NN (_( Santa_NNP Cruz_NNP Biotechnology_NNP )_) ._. The_DT
          phosphorylated_JJ H_NNP 1_CD and_CC pRb_NN bands_NNS were_VBD scanned_JJ and_CC
          quantitated_JJ densitometrically_RB using_VBG a_DT Phosphoimager_NNP
          (_( Molecular_NNP Dynamics_NNP ,_, Sunnyvle_NNP ,_, CA_NNP ,_, USA_NNP )_) ._.
        
        
          Immunofluorescent_NNP staining_VBG
          Exponentially_NNP growing_VBG cells_NNS on_IN slides_NNS were_VBD fixed_VBN in_IN 4_CD %_NN
          paraformaldehyde_NN in_IN PEM_NNP buffer_NN (_( 80_CD mM_NN Pipes_NNP [_NN pH_NN 7_CD ._. 0_CD ]_NN ,_, 5_CD
          mM_NN EGTA_NNP and_CC 2_CD mM_NN MgCl_NNP 
          2_LS )_) for_IN 30_CD min_NN ,_, permeabilized_JJ in_IN 0_CD ._. 5_CD %_NN
          Triton_NNP X-_NNP 100_CD in_IN PEM_NNP buffer_NN at_IN room_NN temperature_NN for_IN 15_CD min_NN
          and_CC rinsed_JJ three_CD times_NNS with_IN TBS_NNP +_NN 0_CD ._. 1_CD %_NN Tween_NNP 20_CD ,_, followed_VBN
          by_IN incubation_NN in_IN 0_CD ._. 5_CD %_NN nonfat_JJ dry_JJ milk_NN in_IN TBS_NNP +_NN 0_CD ._. 1_CD %_NN Tween_NNP
          20_CD for_IN 2_CD h_NN at_IN room_NN temperature_NN ._. For_IN BrdU_NNP and_CC DAPI_NNP double_JJ
          immunostaining_VBG ,_, cells_NNS were_VBD incubated_JJ for_IN 30_CD min_NN in_IN media_NNS
          supplemented_JJ with_IN 5_CD μM_NN BrdU_NNP ._. After_IN 30_CD min_NN ,_, cells_NNS were_VBD
          incubated_JJ in_IN 2_CD N_NNP HCl_NNP for_IN 5_CD min_NN at_IN room_NN temperature_NN prior_RB
          to_TO incubation_NN with_IN the_DT primary_JJ antibody_NN (_( this_DT step_NN was_VBD
          omitted_VBN for_IN pRb-_NN 2_CD /_NN p_NN 130_CD immunostaining_VBG )_) ._. Following_VBG washing_VBG
          three_CD times_NNS ,_, cells_NNS were_VBD incubated_JJ in_IN a_DT (_( 1_CD :_: 50_CD )_) dilution_NN
          of_IN mouse_NN anti-_NN BrdU_NNP monoclonal_NN antibody_NN (_( Boehringer_NNP
          Mannheim_NNP ,_, Indianapolis_NNP ,_, IN_IN ,_, USA_NNP )_) for_IN 2_CD h_NN at_IN 37_CD °_NN C_NNP ._. After_IN
          washing_VBG three_CD times_NNS ,_, cells_NNS were_VBD then_RB incubated_JJ in_IN
          FITC-conjugated_NNP anti-mouse_JJ secondary_JJ antibody_NN (_( 1_CD :_: 400_CD )_)
          dilution_NN for_IN 1_CD h_NN at_IN 37_CD °_NN C_NNP ,_, followed_VBN by_IN washing_VBG three_CD times_NNS
          with_IN anti-fade_JJ equilibrating_VBG buffer_NN and_CC mounting_VBG in_IN
          anti-fade_JJ mounting_VBG medium_NN (_( Molecular_NNP Probe_NNP ,_, Eugene_NNP ,_, OR_NNP ,_,
          USA_NNP )_) ._. The_DT same_JJ sequential_NN steps_NNS were_VBD followed_VBN for_IN
          pRb-_NN 2_CD /_NN p_NN 130_CD immunostaining_VBG using_VBG anti-p_JJ Rb-_NNP 2_CD /_NN p_NN 130_CD
          monoclonal_NN antibodies_NNS (_( Santa_NNP Cruz_NNP Biotechnology_NNP )_) ._.
        
        
          Apoptosis_NNP
          Apoptotic_NNP activities_NNS in_IN TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cells_NNS in_IN the_DT
          absence_NN and_CC presence_NN of_IN 2_CD ._. 5_CD μM_NN SAHA_NNP were_VBD examined_VBN by_IN two_CD
          procedures_NNS :_: the_DT TACS_NNP 2_CD TdT_NNP In_IN Situ_NNP Apoptosis_NNP Detection_NNP
          assay_NN following_VBG the_DT manufacturer_NN 's_POS instructions_NNS
          (_( Trevingen_NNP ,_, Gaithersburg_NNP ,_, MD_NNP ,_, USA_NNP )_) ,_, and_CC the_DT DNA_NNP
          Fragmentation_NNP Assay_NNP described_VBD elsewhere_RB [_NN 29_CD ]_NN ._.
        
      
      
        Results_NNS
        
          Effect_NN of_IN SAHA_NNP on_IN TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN proliferation_NN
          and_CC morphology_NN
          The_DT TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN lines_NNS were_VBD used_VBN to_TO investigate_VB
          whether_IN the_DT status_NN of_IN p_NN 53_CD influences_VBZ the_DT outcome_NN of_IN SAHA_NNP
          treatment_NN ._. The_DT origin_NN of_IN TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN lines_NNS was_VBD
          described_VBN earlier_JJR [_NN 30_CD ]_NN ._. The_DT rate_NN of_IN cell_NN proliferation_NN
          at_IN concentrations_NNS of_IN 0_CD ,_, 1_CD ._. 0_CD ,_, 2_CD ._. 5_CD ,_, 5_CD ,_, and_CC 10_CD μM_NN SAHA_NNP was_VBD
          examined_VBN by_IN [_NN 3_CD H_NNP ]_NN -_: thymidine_NN assay_NN at_IN the_DT indicated_VBN time_NN
          points_NNS ._. The_DT inhibitory_NN effect_NN of_IN SAHA_NNP at_IN concentrations_NNS
          of_IN 2_CD ._. 5_CD μM_NN and_CC higher_RBR on_IN cell_NN proliferation_NN was_VBD profound_JJ
          on_IN both_DT cell_NN lines_NNS after_IN 24_CD h_NN ._. The_DT TM_NNP 10_CD cell_NN
          proliferation_NN continued_VBD to_TO be_VB inhibited_VBD during_IN the_DT
          following_VBG 5_CD days_NNS in_IN the_DT presence_NN of_IN SAHA_NNP ,_, whereas_IN minimal_JJ
          growth_NN in_IN TM_NNP 2_CD H_NNP cell_NN growth_NN on_IN days_NNS 3_CD and_CC 4_CD was_VBD observed_VBN
          (_( Figs_NNP 1_CD A_DT ,_, C_NNP )_) ._. After_IN removing_VBG SAHA_NNP from_IN the_DT cultures_NNS
          following_VBG 2_CD days_NNS of_IN exposure_NN to_TO all_DT SAHA_NNP concentrations_NNS ,_,
          TM_NNP 10_CD cells_NNS continued_VBD to_TO be_VB inhibited_VBD at_IN concentrations_NNS of_IN
          2_CD ._. 5_CD μM_NN and_CC higher_JJR during_IN the_DT following_VBG 4_CD days_NNS of_IN SAHA_NNP
          free_JJ cultures_NNS (_( Fig_NNP ._. 1_LS B_NNP )_) ,_, whereas_IN TM_NNP 2_CD H_NNP cells_NNS resumed_VBD
          proliferation_NN (_( Fig_NNP ._. 1_LS D_NNP )_) ._. These_DT results_NNS suggest_VBP that_IN SAHA_NNP
          induced_VBN a_DT dose-dependent_JJ block_NN in_IN DNA_NNP replication_NN on_IN both_DT
          cell_NN lines_NNS ._. A_DT 2_CD ._. 5_CD μM_NN dose_NN of_IN SAHA_NNP was_VBD used_VBN in_IN further_JJ
          experiments_NNS because_IN this_DT concentration_NN seems_VBZ to_TO be_VB
          unequivocally_RB effective_JJ on_IN cell_NN growth_NN inhibition_NN on_IN both_DT
          cell_NN lines_NNS after_IN 24_CD h_NN of_IN treatment_NN ._. Furthermore_RB ,_, no_DT
          apoptotic_JJ activity_NN was_VBD observed_VBN after_IN 24_CD and_CC 48_CD h_NN of_IN
          treatment_NN with_IN 2_CD ._. 5_CD μM_NN SAHA_NNP in_IN both_DT cell_NN lines_NNS (_( data_NNS not_RB
          shown_VBN )_) ._.
          The_DT effect_NN of_IN SAHA_NNP on_IN blocking_VBG cell_NN proliferation_NN
          through_IN blocking_VBG DNA_NNP synthesis_NN was_VBD examined_VBN by_IN BrdU_NNP
          labeling_VBG ,_, as_IN determined_VBN by_IN immunofluorescence_NN staining_VBG
          (_( Fig_NNP ._. 2_LS A_DT )_) ,_, and_CC the_DT cell_NN cycle_NN profile_NN by_IN flow_NN cytometric_JJ
          analysis_NN (_( Fig_NNP ._. 2_LS B_NNP )_) ._. The_DT BrdU_NNP indices_NNS in_IN the_DT control_JJ TM_NNP 10_CD
          and_CC TM_NNP 2_CD H_NNP cells_NNS ,_, including_VBG all_DT types_NNS of_IN BrdU_NNP staining_VBG
          patterns_NNS ,_, were_VBD 16_CD and_CC 34_CD %_NN ,_, respectively_RB ,_, indicating_VBG that_IN
          the_DT percentage_NN of_IN TM_NNP 2_CD H_NNP cells_NNS synthesizing_VBG DNA_NNP or_CC in_IN the_DT
          'S_VBZ phase_NN '_'' were_VBD more_RBR than_IN double_JJ that_IN of_IN TM_NNP 10_CD cells_NNS (_( Fig_NNP ._.
          2_LS A_DT )_) ._. Upon_IN 2_CD ._. 5_CD μM_NN SAHA_NNP treatment_NN for_IN 24_CD h_NN ,_, 800_CD cells_NNS per_IN
          sample_NN were_VBD counted_VBN stained_JJ with_IN BrdU_NNP against_IN cells_NNS
          stained_JJ with_IN DAPI_NNP ,_, and_CC BrdU_NNP labeling_VBG indices_NNS dropped_VBD
          dramatically_RB to_TO 4_CD and_CC 6_CD %_NN in_IN TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cells_NNS ,_,
          respectively_RB ._. Furthermore_RB ,_, the_DT BrdU_NNP staining_VBG revealed_VBN the_DT
          size_NN and_CC pattern_NN of_IN replication_NN clusters_NNS ,_, which_WDT are_VBP
          related_VBN to_TO the_DT general_JJ patterns_NNS of_IN DNA_NNP replication_NN in_IN
          mammalian_JJ cell_NN nuclei_NN at_IN early_JJ ,_, mid_JJ and_CC late_JJ S_NNP phase_NN [_NN
          31_CD ]_NN ._. These_DT data_NNS suggested_VBD that_IN 2_CD ._. 5_CD μM_NN SAHA_NNP was_VBD capable_JJ of_IN
          inhibiting_VBG cell_NN proliferation_NN in_IN both_DT TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN
          lines_NNS by_IN blocking_VBG DNA_NNP synthesis_NN ,_, regardless_RB of_IN their_PRP$
          differences_NNS in_IN the_DT number_NN of_IN cells_NNS synthesizing_VBG DNA_NNP ._.
          These_DT results_NNS were_VBD confirmed_VBN by_IN flow_NN cytometric_JJ
          analysis_NN after_IN staining_VBG cells_NNS with_IN BrdU_NNP for_IN newly_RB
          synthesized_JJ DNA_NNP and_CC with_IN propidium_NN iodide_NN for_IN DNA_NNP
          content_NN ._. The_DT percentages_NNS of_IN cells_NNS in_IN the_DT G_NNP 1_CD and_CC S_NNP phases_NNS
          in_IN control_NN TM_NNP 10_CD cells_NNS at_IN the_DT time_NN of_IN treatment_NN were_VBD 57_CD
          and_CC 18_CD %_NN ,_, respectively_RB ,_, and_CC those_DT for_IN TM_NNP 2_CD H_NNP cells_NNS were_VBD 39_CD
          and_CC 28_CD %_NN ,_, respectively_RB (_( Fig_NNP ._. 2_LS B_NNP )_) ._. The_DT number_NN of_IN TM_NNP 2_CD H_NNP cells_NNS
          growth_NN arrested_VBN in_IN the_DT G_NNP 1_CD phase_NN upon_IN SAHA_NNP treatment_NN for_IN
          24_CD h_NN increased_VBD by_IN 21_CD %_NN ,_, compared_VBN with_IN the_DT 8_CD %_NN increase_NN in_IN
          the_DT TM_NNP 10_CD cell_NN line_NN ,_, concomitant_NN with_IN similar_JJ differences_NNS
          in_IN the_DT percentage_NN of_IN cells_NNS inhibited_VBD in_IN the_DT S_NNP and_CC G_NNP 2_CD /_NN M_NNP
          phases_NNS (_( Fig_NNP ._. 2_LS B_NNP )_) ._. This_DT difference_NN in_IN G_NNP 1_CD cell_NN growth_NN
          arrest_NN between_IN the_DT two_CD cell_NN lines_NNS may_MD be_VB attributed_VBN to_TO
          their_PRP$ differences_NNS in_IN the_DT initial_JJ number_NN of_IN cells_NNS
          distributed_VBN in_IN each_DT cell_NN cycle_NN phase_NN before_IN
          treatment_NN ._.
          The_DT shape_NN and_CC morphology_NN of_IN TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cells_NNS grown_VBN
          on_IN slides_NNS in_IN the_DT presence_NN and_CC absence_NN of_IN 2_CD ._. 5_CD μM_NN SAHA_NNP were_VBD
          examined_VBN ._. The_DT dimensions_NNS of_IN 50_CD randomly_RB selected_VBN cells_NNS of_IN
          each_DT cell_NN line_NN were_VBD measured_VBN using_VBG a_DT microscope_NN scale_NN ._.
          The_DT TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP mammary_JJ epithelial_NN cells_NNS measured_VBD 5_CD ._. 4_CD ±_NN
          2_CD ._. 1_CD and_CC 3_CD ._. 6_CD ±_NN 1_CD ._. 4_CD μm_NN in_IN width_NN and_CC 13_CD ._. 7_CD ±_NN 5_CD ._. 9_CD and_CC 18_CD ._. 6_CD ±_NN
          8_CD ._. 0_CD μm_NN in_IN length_NN ,_, respectively_RB ._. TM_NNP 10_CD cells_NNS generally_RB had_VBD
          five_CD to_TO seven_CD extensions_NNS ,_, whereas_IN TM_NNP 2_CD H_NNP cells_NNS had_VBD three_CD to_TO
          five_CD extensions_NNS ._. TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cells_NNS became_VBD flattened_VBN and_CC
          increased_VBN in_IN both_DT nuclear_JJ and_CC cytoplasmic_JJ volume_NN after_IN 24_CD
          h_NN of_IN 2_CD ._. 5_CD μM_NN SAHA_NNP treatment_NN ._. Both_DT cells_NNS exhibited_VBN less_RBR
          distinct_JJ intracellular_NN borders_NNS (_( Fig_NNP ._. 3_LS )_) ._. The_DT morphology_NN
          of_IN both_DT cell_NN lines_NNS was_VBD similar_JJ to_TO cells_NNS committed_VBN to_TO cell_NN
          differentiation_NN ;_: however_RB ,_, these_DT mammary_JJ cells_NNS grown_VBN on_IN
          plastic_NN dishes_NNS were_VBD unable_JJ to_TO differentiate_VB by_IN SAHA_NNP ._.
        
        
          Effect_NN of_IN SAHA_NNP on_IN histone_NN protein_NN and_CC acetylation_NN
          levels_NNS in_IN TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN lines_NNS
          It_PRP is_VBZ not_RB known_VBN whether_IN SAHA_NNP alters_NNS the_DT protein_NN
          acetylation_NN levels_NNS of_IN various_JJ histones_NNS in_IN the_DT mammary_JJ
          epithelial_NN cells_NNS ._. Changes_NNS in_IN the_DT acetylation_NN or_CC
          phosphorylation_NN of_IN histones_NNS result_VBP in_IN alterations_NNS that_WDT
          can_MD be_VB visualized_JJ as_IN changes_NNS in_IN protein_NN mobility_NN on_IN an_DT
          acid-urea_JJ gel_NN following_VBG western_JJ blot_NN analysis_NN [_NN 26_CD ,_, 27_CD ]_NN ._.
          These_DT gels_NNS separate_JJ histones_NNS on_IN the_DT basis_NN of_IN charges_NNS as_RB
          well_RB as_IN size_NN ,_, resulting_VBG in_IN multiple_JJ bands_NNS for_IN each_DT
          histone_NN that_WDT correspond_VB to_TO differently_RB modified_VBN isoforms_NNS ._.
          These_DT isoforms_NNS can_MD be_VB identified_VBN by_IN their_PRP$ characteristic_JJ
          mobility_NN and_CC by_IN staining_VBG with_IN antibodies_NNS specific_JJ to_TO each_DT
          histone_NN isoform_NN [_NN 26_CD ]_NN ._. Protein_NNP and_CC acetylation_NN levels_NNS of_IN
          histone_NN H_NNP 3_CD and_CC H_NNP 4_CD isoforms_NNS on_IN histone_NN samples_NNS isolated_VBN
          from_IN SAHA_NNP treated_VBD and_CC untreated_JJ TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cells_NNS
          stained_JJ by_IN Coomassie_NNP Brilliant_NNP Blue_NNP (_( Fig_NNP ._. 4_LS A_DT )_) and_CC by_IN
          western_JJ blots_NNS (_( Fig_NNP ._. 4_LS B_NNP )_) were_VBD examined_VBN to_TO identify_VB the_DT
          potency_NN of_IN SAHA_NNP as_IN a_DT histone_NN deacetylase_NN inhibitor_NN on_IN
          mammary_JJ epithelial_NN cells_NNS ._. We_PRP focused_VBD on_IN H_NNP 3_CD and_CC H_NNP 4_CD because_IN
          antibodies_NNS are_VBP available_JJ and_CC acetylation_NN events_NNS in_IN those_DT
          histones_NNS have_VBP been_VBN studied_VBN ._. These_DT results_NNS suggested_VBD that_IN
          SAHA_NNP not_RB only_RB increased_VBN histone_NN acetylation_NN ,_, as_IN shown_VBN in_IN
          H_NNP 4_CD (_( Fig_NNP ._. 4_LS A_DT )_) ,_, but_CC also_RB increased_VBN histone_NN protein_NN levels_NNS
          in_IN TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cells_NNS (_( Fig_NNP ._. 4_LS B_NNP )_) ._. The_DT increases_NNS in_IN
          protein_NN and_CC acetylation_NN levels_NNS of_IN H_NNP 3_CD and_CC H_NNP 4_CD in_IN SAHA_NNP
          treated_VBD TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN lines_NNS were_VBD indicated_VBN by_IN the_DT
          strong_JJ staining_VBG with_IN the_DT acetylation_NN specific_JJ antibodies_NNS
          of_IN H_NNP 3_CD and_CC H_NNP 4_CD ,_, while_IN the_DT acetylated_JJ slow_JJ migrated_JJ isoforms_NNS
          showed_VBD smearing_VBG due_JJ to_TO the_DT increases_NNS in_IN their_PRP$ protein_NN
          level_NN (_( Fig_NNP ._. 5_LS B_NNP )_) ._. We_PRP did_VBD not_RB ,_, however_RB ,_, observe_VBP differences_NNS
          in_IN the_DT initial_JJ acetylation_NN levels_NNS between_IN untreated_JJ TM_NNP 10_CD
          and_CC TM_NNP 2_CD H_NNP cell_NN lines_NNS ._.
        
        
          SAHA_NNP induced_VBD hypophosphorylation_NN of_IN all_PDT the_DT three_CD
          pocket_NN proteins_NNS
          Phosphorylation_NNP of_IN three_CD major_JJ pocket_NN proteins_NNS ,_, Rb_NNP ,_,
          p_NN 107_CD and_CC Rb_NNP 2_CD /_NN p_NN 130_CD ,_, were_VBD examined_VBN after_IN SAHA_NNP treatment_NN ,_, as_IN
          each_DT pocket_NN protein_NN affects_VBZ the_DT G_NNP 1_CD and_CC S_NNP phases_NNS of_IN the_DT
          cell_NN cycle_NN ._. Upon_IN treatment_NN with_IN 2_CD ._. 5_CD μM_NN SAHA_NNP for_IN 24_CD h_NN ,_, a_DT
          profound_JJ increase_NN in_IN hypophosphorylation_NN of_IN the_DT three_CD
          pocket_NN proteins_NNS was_VBD observed_VBN in_IN both_DT TM_NNP 10_CD and_CC to_TO a_DT lesser_JJR
          extent_NN in_IN TM_NNP 2_CD H_NNP cells_NNS as_IN compared_VBN with_IN their_PRP$ control_NN
          counterparts_NNS ,_, judged_VBN by_IN the_DT faster_JJR mobility_NN of_IN the_DT Rb_NNP
          pocket_NN protein_NN isoforms_NNS on_IN SDS_NNP gel_NN (_( Fig_NNP ._. 5_LS )_) ._. The_DT
          difference_NN in_IN the_DT level_NN of_IN hypophosphorylated_JJ pRb_NN pocket_NN
          protein_NN isoforms_NNS between_IN the_DT two_CD cell_NN lines_NNS treated_VBN with_IN
          SAHA_NNP may_MD be_VB attributed_VBN to_TO differences_NNS in_IN G_NNP 1_CD and_CC S_NNP phase_NN
          cdk_NN activity_NN (_( examined_VBD in_IN the_DT following_VBG section_NN )_) ._. Results_NNS
          suggested_VBD that_IN SAHA_NNP induced_VBD cell_NN growth_NN arrest_NN through_IN
          dephosphorylation_NN of_IN three_CD pRb_NN pocket_NN proteins_NNS ,_, which_WDT may_MD
          be_VB related_VBN to_TO inhibition_NN in_IN G_NNP 1_CD /_NN S_NNP phase_NN cdk_NN
          activities_NNS ._.
        
        
          SAHA_NNP inhibits_NNS multiple_JJ cyclin-associated_JJ kinase_NN
          activities_NNS
          There_EX are_VBP extensive_JJ studies_NNS on_IN the_DT relation_NN between_IN
          specific_JJ phosphorylation_NN sites_NNS on_IN pRb_NN and_CC its_PRP$ potential_JJ
          transcription_NN repression_NN [_NN 32_CD ,_, 33_CD ,_, 34_CD ]_NN ._. It_PRP is_VBZ well_RB known_VBN
          that_DT pRb_NN phosphorylation_NN sites_NNS are_VBP recognized_VBN by_IN specific_JJ
          cdks_NNS [_NN 33_CD ]_NN ,_, and_CC that_IN most_JJS of_IN the_DT 16_CD pRb-phosphorylation_JJ
          sites_NNS are_VBP sequentially_RB phosphorylated_JJ throughout_IN the_DT cell_NN
          cycle_NN (_( reviewed_VBN in_IN [_NN 34_CD ,_, 35_CD ]_NN )_) ._. SAHA_NNP treatment_NN resulted_VBD in_IN
          G_NNP 1_CD cell_NN growth_NN arrest_NN in_IN TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN lines_NNS ,_,
          concomitant_NN with_IN the_DT profound_JJ increase_NN in_IN
          dephosphorylation_NN of_IN the_DT three_CD pRb_NN pocket_NN proteins_NNS ._.
          Therefore_RB ,_, we_PRP examined_VBD cyclin_NN D_NNP 1_CD ,_, E_NNP and_CC A_DT cdk_NN 2_CD activities_NNS
          in_IN TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN cultures_NNS after_IN 24_CD h_NN treatment_NN with_IN
          SAHA_NNP because_IN they_PRP reflect_VBP kinase_NN activities_NNS before_RB ,_,
          during_IN and_CC after_IN the_DT G_NNP 1_CD →_NN S_NNP checkpoint_NN ,_, respectively_RB ._. The_DT
          three_CD cyclin_NN /_NN cdk_NN 2_CD complexes_NNS directly_RB reflect_VBP the_DT
          sequential_NN events_NNS in_IN DNA_NNP synthesis_NN [_NN 36_CD ]_NN ._. The_DT initial_JJ
          levels_NNS of_IN cyclin_NN D_NNP 1_CD ,_, E_NNP and_CC A_DT associated_VBN kinase_NN activities_NNS
          were_VBD 3_CD -_: ,_, 2_CD ._. 5_CD -_: and_CC 4_CD -_: fold_VB higher_JJR in_IN untreated_JJ TM_NNP 2_CD H_NNP
          compared_VBD with_IN TM_NNP 10_CD cells_NNS ,_, respectively_RB (_( Fig_NNP ._. 6_CD A_DT B_NNP C_NNP )_) ._.
          These_DT results_NNS were_VBD predicted_VBN based_VBN on_IN their_PRP$ differences_NNS
          in_IN cell_NN distribution_NN throughout_IN the_DT cell_NN cycle_NN ,_, as_IN
          appeared_VBN in_IN the_DT cell_NN cycle_NN profile_NN analysis_NN ,_, and_CC may_MD
          reflect_VB the_DT cell_NN line_NN differences_NNS in_IN known_VBN p_NN 53_CD status_NN ._.
          Cyclin_NNP D_NNP 1_CD ,_, E_NNP and_CC A_DT associated_VBN kinase_NN activities_NNS decreased_VBN
          by_IN four-_NN ,_, four-_NN ,_, and_CC fivefold_JJ ,_, respectively_RB ,_, in_IN TM_NNP 10_CD
          cells_NNS compared_VBN with_IN control_NN on_IN SAHA_NNP treatment_NN ,_, whereas_IN
          only_RB cyclin_NN D_NNP 1_CD and_CC A_DT associated_VBN kinase_NN activities_NNS
          decreased_VBD (_( 2_CD ._. 2_LS -_: and_CC 2_CD ._. 6_CD -_: fold_VB ,_, respectively_RB )_) in_IN SAHA_NNP
          treated_VBD TM_NNP 2_CD H_NNP cells_NNS compared_VBN with_IN control_NN (_( Fig_NNP ._. 6_CD )_) ._. These_DT
          data_NNS demonstrate_VBP that_IN SAHA_NNP inhibits_NNS multiple_JJ cdk_NN
          activities_NNS ,_, and_CC the_DT degree_NN of_IN inhibition_NN was_VBD more_RBR
          profound_JJ in_IN TM_NNP 10_CD verses_NNS TM_NNP 2_CD H_NNP cells_NNS ._.
        
        
          Effect_NN of_IN SAHA_NNP on_IN p_NN 21_CD ,_, PCNA_NNP ,_, E_NNP 2_CD F-_NNP 1_CD and_CC E_NNP 2_CD F-_NNP 4_CD
          proteins_NNS as_IN a_DT function_NN of_IN cell_NN growth_NN inhibition_NN
          The_DT difference_NN in_IN the_DT protein_NN level_NN of_IN p_NN 21_CD /_NN Cip_NNP 1_CD
          between_IN TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN lines_NNS was_VBD predicted_VBN based_VBN on_IN
          their_PRP$ differences_NNS in_IN p_NN 53_CD status_NN (_( Fig_NNP ._. 7_CD A_DT )_) ._. Perinuclear_NNP
          localization_NN of_IN p_NN 21_CD was_VBD detected_VBN in_IN only_RB few_JJ TM_NNP 2_CD H_NNP cells_NNS
          (_( p_NN 53_CD null_NN )_) when_WRB both_DT cell_NN lines_NNS were_VBD immunostained_JJ for_IN
          p_NN 21_CD ,_, whereas_IN p_NN 21_CD was_VBD localized_JJ in_IN both_DT cytoplasmic_JJ and_CC
          nuclear_JJ compartments_NNS in_IN TM_NNP 10_CD cells_NNS (_( p_NN 53_CD wt_NN )_) (_( data_NNS not_RB
          shown_VBN )_) ._. The_DT p_NN 21_CD expression_NN level_NN decreased_VBN by_IN 50_CD %_NN in_IN TM_NNP 10_CD
          cells_NNS upon_IN SAHA_NNP treatment_NN (_( Fig_NNP ._. 7_CD A_DT )_) ._. These_DT results_NNS
          suggest_VBP that_IN SAHA_NNP inhibited_VBD DNA_NNP synthesis_NN in_IN the_DT presence_NN
          or_CC absence_NN of_IN p_NN 21_CD protein_NN ._.
          PCNA_NNP [_NN 37_CD ]_NN and_CC E_NNP 2_CD F-_NNP 1_CD [_NN 1_CD ,_, 7_CD ]_NN are_VBP two_CD key_JJ mediators_NNS of_IN
          the_DT G_NNP 1_CD →_NN S_NNP transition_NN and_CC DNA_NNP synthesis_NN ._. Because_IN such_JJ
          regulatory_JJ proteins_NNS can_MD be_VB present_JJ at_IN different_JJ levels_NNS
          and_CC in_IN different_JJ molecular_JJ complexes_NNS in_IN nuclei_NN as_IN
          compared_VBN with_IN the_DT cytoplasm_NN ,_, separation_NN of_IN the_DT two_CD
          cellular_JJ compartments_NNS allowed_VBD an_DT assessment_NN of_IN the_DT
          site_NN (_( s_VBZ )_) at_IN which_WDT these_DT proteins_NNS exert_VB their_PRP$ primary_JJ
          activity_NN unimpeded_JJ by_IN artifacts_NNS that_WDT may_MD result_VB from_IN
          intermixing_VBG the_DT two_CD compartments_NNS ._. In_IN the_DT untreated_JJ cells_NNS ,_,
          the_DT cytoplasmic_JJ PCNA_NNP protein_NN levels_NNS in_IN TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN
          lines_NNS were_VBD similar_JJ ,_, but_CC the_DT level_NN of_IN PCNA_NNP in_IN the_DT nuclear_JJ
          fraction_NN was_VBD fourfold_NN higher_JJR in_IN TM_NNP 2_CD H_NNP cells_NNS compared_VBN with_IN
          TM_NNP 10_CD cells_NNS (_( Fig_NNP ._. 7_CD B_NNP )_) ._. The_DT effect_NN of_IN SAHA_NNP was_VBD profound_JJ on_IN
          the_DT nuclear_JJ PCNA_NNP fraction_NN in_IN both_DT cell_NN lines_NNS ,_, but_CC minimal_JJ
          on_IN the_DT cytoplasmic_JJ PCNA_NNP fraction_NN ._. The_DT pronounced_VBN
          difference_NN in_IN the_DT levels_NNS of_IN PCNA_NNP in_IN growing_VBG versus_CC
          arrested_VBN cells_NNS is_VBZ in_IN accordance_NN with_IN the_DT determinant_NN role_NN
          PCNA_NNP plays_VBZ in_IN DNA_NNP synthesis_NN [_NN 37_CD ,_, 38_CD ]_NN ._.
          To_TO further_VB investigate_VB the_DT effect_NN of_IN SAHA_NNP on_IN
          inhibition_NN of_IN DNA_NNP synthesis_NN ,_, we_PRP examined_VBD E_NNP 2_CD F-_NNP 1_CD as_IN a_DT key_JJ
          mediator_NN for_IN G_NNP 1_CD →_NN S_NNP transition_NN and_CC DNA_NNP synthesis_NN ._. The_DT
          initial_JJ nuclear_JJ protein_NN level_NN of_IN E_NNP 2_CD F-_NNP 1_CD in_IN the_DT untreated_JJ
          TM_NNP 2_CD H_NNP cells_NNS was_VBD 4_CD ._. 8_CD -_: fold_VB higher_JJR compared_VBN with_IN the_DT TM_NNP 10_CD
          cell_NN line_NN (_( Fig_NNP ._. 7_CD C_NNP )_) ._. Nuclear_NNP E_NNP 2_CD F-_NNP 1_CD protein_NN was_VBD completely_RB
          abolished_VBN in_IN TM_NNP 10_CD cells_NNS after_IN 24_CD h_NN of_IN SAHA_NNP treatment_NN ,_, and_CC
          decreased_VBD 2_CD ._. 2_CD -_: fold_VB in_IN TM_NNP 2_CD H_NNP cells_NNS (_( Fig_NNP ._. 7_CD C_NNP )_) ._. These_DT results_NNS
          demonstrate_VBP that_IN SAHA_NNP treatment_NN also_RB inhibits_NNS E_NNP 2_CD F-_NNP 1_CD
          protein_NN levels_NNS ._.
          It_PRP has_VBZ been_VBN reported_VBN that_DT expression_NN of_IN 
          E_NNP 2_CD F-_NNP 4_CD gene_NN does_VBZ not_RB change_VB in_IN
          relation_NN to_TO cell_NN growth_NN ,_, although_IN a_DT modest_JJ increase_NN can_MD
          sometimes_RB be_VB observed_VBN in_IN growing_VBG cells_NNS [_NN 39_CD ]_NN ._. E_NNP 2_CD F-_NNP 4_CD
          protein_NN levels_NNS were_VBD examined_VBN in_IN the_DT nuclear_JJ and_CC
          cytoplasmic_JJ fractions_NNS in_IN both_DT cell_NN lines_NNS with_IN and_CC without_IN
          SAHA_NNP ,_, and_CC the_DT protein_NN levels_NNS did_VBD not_RB change_VB upon_IN SAHA_NNP
          treatment_NN in_IN either_DT fractions_NNS of_IN either_DT cell_NN line_NN (_( Fig_NNP ._.
          7_CD D_NNP )_) ._. It_PRP is_VBZ noteworthy_JJ that_IN the_DT mechanism_NN of_IN SAHA_NNP in_IN G_NNP 1_CD
          cell_NN growth_NN arrest_NN may_MD target_VB the_DT expression_NN of_IN specific_JJ
          proteins_NNS involved_VBN in_IN DNA_NNP synthesis_NN as_IN it_PRP inhibited_VBD E_NNP 2_CD F-_NNP 1_CD
          and_CC PCNA_NNP ,_, but_CC not_RB E_NNP 2_CD F-_NNP 4_CD ,_, suggesting_VBG that_IN SAHA_NNP may_MD cause_VB
          different_JJ levels_NNS of_IN histone_NN acetylation_NN at_IN distinct_JJ
          regions_NNS of_IN the_DT genome_NN ._.
          Rb_NNP 2_CD /_NN p_NN 130_CD subcellular_NN localization_NN and_CC interaction_NN with_IN
          E_NNP 2_CD F-_NNP 4_CD was_VBD examined_VBN in_IN both_DT cell_NN lines_NNS in_IN the_DT absence_NN and_CC
          presence_NN of_IN SAHA_NNP because_IN Rb_NNP 2_CD /_NN p_NN 130_CD is_VBZ an_DT important_JJ
          cytoplasmic_JJ partner_NN of_IN E_NNP 2_CD F-_NNP 4_CD and_CC is_VBZ capable_JJ of_IN inducing_VBG
          nuclear_JJ localization_NN of_IN the_DT complex_NN upon_IN cell_NN growth_NN
          arrest_NN and_CC differentiation_NN [_NN 40_CD ,_, 41_CD ]_NN ._. Immunostaining_NNP
          analysis_NN using_VBG monoclonal_NN antibody_NN specific_JJ for_IN pRb_NN 2_CD /_NN p_NN 130_CD
          revealed_VBD that_IN SAHA_NNP enhanced_JJ pRb_NN 2_CD /_NN p_NN 130_CD nuclear_JJ
          localization_NN in_IN both_DT cell_NN lines_NNS treated_VBN with_IN SAHA_NNP for_IN 24_CD
          h_NN compared_VBN with_IN their_PRP$ controls_NNS (_( Fig_NNP ._. 8_CD A_DT )_) ._. To_TO examine_VB
          whether_IN the_DT increase_NN in_IN hypophosphorylation_NN of_IN pRb_NN 2_CD /_NN p_NN 130_CD
          (_( Fig_NNP ._. 5_LS )_) and_CC its_PRP$ nuclear_JJ localization_NN after_IN SAHA_NNP
          treatment_NN was_VBD associated_VBN with_IN interaction_NN to_TO E_NNP 2_CD F-_NNP 4_CD ,_, equal_JJ
          amounts_NNS of_IN nuclear_JJ protein_NN extracts_NNS were_VBD
          immunoprecipitated_JJ with_IN antibodies_NNS against_IN E_NNP 2_CD F-_NNP 4_CD followed_VBN
          by_IN western_JJ blot_NN analysis_NN against_IN pRb_NN 2_CD /_NN p_NN 130_CD antibodies_NNS ._.
          Interestingly_RB ,_, the_DT results_NNS revealed_VBD an_DT unequivocal_NN
          increase_NN in_IN the_DT nuclear_JJ pRb_NN 2_CD /_NN p_NN 130_CD protein_NN level_NN
          associated_VBN with_IN E_NNP 2_CD F-_NNP 4_CD in_IN both_DT cell_NN lines_NNS treated_VBN with_IN
          SAHA_NNP (_( Fig_NNP ._. 8_CD B_NNP )_) ._. These_DT intriguing_JJ results_NNS indicate_VBP that_IN
          the_DT interaction_NN of_IN hypophosphorylated_JJ pRb_NN 2_CD /_NN p_NN 130_CD with_IN
          E_NNP 2_CD F-_NNP 4_CD followed_VBN by_IN enhancement_NN in_IN nuclear_JJ location_NN after_IN
          SAHA_NNP treatment_NN is_VBZ a_DT novel_NN mechanism_NN in_IN SAHA-mediating_NNP
          cell_NN growth_NN arrest_NN ._.
        
      
      
        Discussion_NNP
        In_IN this_DT study_NN ,_, we_PRP present_JJ novel_NN data_NNS on_IN the_DT mechanism_NN of_IN
        SAHA_NNP in_IN cell_NN growth_NN arrest_NN on_IN two_CD mouse_NN mammary_JJ epithelial_NN
        cell_NN lines_NNS ,_, TM_NNP 10_CD (_( p_NN 53_CD wt_NN )_) and_CC TM_NNP 2_CD H_NNP (_( p_NN 53_CD null_NN )_) ._. SAHA_NNP was_VBD
        able_JJ to_TO increase_VB histone_NN H_NNP 3_CD and_CC H_NNP 4_CD protein_NN and_CC acetylation_NN
        levels_NNS ,_, and_CC caused_VBD a_DT profound_JJ decrease_NN in_IN the_DT protein_NN
        levels_NNS of_IN key_JJ molecules_NNS ,_, PCNA_NNP and_CC E_NNP 2_CD F-_NNP 1_CD ,_, essential_JJ for_IN DNA_NNP
        synthesis_NN ._. Furthermore_RB ,_, SAHA_NNP significantly_RB enhanced_VBD the_DT
        interaction_NN of_IN pRb_NN 2_CD /_NN p_NN 130_CD to_TO E_NNP 2_CD F-_NNP 4_CD and_CC the_DT nuclear_JJ
        localization_NN of_IN the_DT pRb_NN 2_CD /_NN p_NN 130_CD -_: E_NNP 2_CD F-_NNP 4_CD complex_JJ ._. SAHA_NNP also_RB
        resulted_VBD in_IN the_DT inhibition_NN of_IN G_NNP 1_CD /_NN S_NNP kinase_NN activities_NNS and_CC ,_,
        consequently_RB ,_, hypophosphorylation_NN of_IN the_DT three_CD pRb_NN pocket_NN
        proteins_NNS ,_, which_WDT led_VBD to_TO G_NNP 1_CD cell_NN growth_NN arrest_NN and_CC dramatic_JJ
        decreases_NNS in_IN DNA_NNP synthesis_NN in_IN both_DT cell_NN lines_NNS ._. TM_NNP 10_CD cells_NNS
        continued_VBD to_TO be_VB inhibited_VBD for_IN 4_CD days_NNS upon_IN removing_VBG SAHA_NNP
        after_IN 2_CD days_NNS of_IN treatment_NN ,_, whereas_IN TM_NNP 2_CD H_NNP cells_NNS were_VBD able_JJ to_TO
        recover_VB their_PRP$ proliferation_NN potentials_NNS ._. A_DT summary_NN of_IN the_DT
        differences_NNS in_IN the_DT molecular_JJ status_NN and_CC cell_NN cycle_NN profile_NN
        between_IN TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN lines_NNS before_IN SAHA_NNP treatment_NN are_VBP
        summarized_VBD in_IN Table_NNP 1_CD ._. These_DT differences_NNS in_IN p_NN 21_CD protein_NN and_CC
        BrdU_NNP index_NN were_VBD predicted_VBN based_VBN on_IN p_NN 53_CD status_NN of_IN these_DT two_CD
        cell_NN lines_NNS and_CC are_VBP in_IN parallel_JJ with_IN other_JJ reports_NNS on_IN
        mammary_JJ tumors_NNS ,_, where_WRB the_DT absence_NN of_IN p_NN 53_CD results_NNS primarily_RB
        in_IN greater_JJR proliferation_NN response_NN in_IN the_DT affected_VBN cell_NN [_NN
        42_CD ]_NN ._. No_DT differences_NNS in_IN histone_NN H_NNP 3_CD and_CC H_NNP 4_CD acetylation_NN levels_NNS
        were_VBD ,_, however_RB ,_, observed_VBD in_IN relation_NN to_TO p_NN 53_CD status_NN between_IN
        the_DT two_CD cell_NN lines_NNS ._. It_PRP is_VBZ not_RB known_VBN at_IN this_DT point_NN whether_IN
        specific_JJ mutations_NNS of_IN p_NN 53_CD alter_VB the_DT degree_NN of_IN histone_NN
        acetylation_NN in_IN cells_NNS ._. Histone_NNP acetylation_NN and_CC p_NN 53_CD mutation_NN
        appear_VBP not_RB to_TO be_VB correlated_JJ in_IN this_DT study_NN ;_: nevertheless_RB ,_, it_PRP
        is_VBZ necessary_JJ and_CC more_RBR sensitive_JJ to_TO examine_VB histone_NN
        acetylase_NN and_CC deacetylase_NN activities_NNS in_IN correlation_NN to_TO p_NN 53_CD
        status_NN ._.
        The_DT mechanism_NN of_IN SAHA_NNP in_IN blocking_VBG DNA_NNP synthesis_NN ,_, as_IN
        demonstrated_VBN by_IN flow_NN cytometric_JJ analysis_NN ,_, appeared_VBD similar_JJ
        in_IN both_DT TM_NNP 10_CD and_CC TM_NNP 2_CD H_NNP cell_NN lines_NNS ,_, and_CC implicated_VBN several_JJ
        events_NNS ._. First_LS ,_, SAHA_NNP increased_VBD histones_NNS H_NNP 3_CD and_CC H_NNP 4_CD protein_NN
        levels_NNS after_IN 24_CD h_NN of_IN treatment_NN ,_, which_WDT could_MD result_VB in_IN cell_NN
        cycle_NN arrest_NN ._. It_PRP has_VBZ been_VBN reported_VBN that_DT upregulation_NN of_IN
        KIAA_NNP 0128_CD gene_NN expression_NN ,_, which_WDT has_VBZ been_VBN implicated_VBN in_IN
        activation_NN of_IN histone_NN mRNA_NN synthesis_NN ,_, was_VBD related_VBN to_TO cell_NN
        cycle_NN arrest_NN in_IN MCF-_NNP 7_CD cells_NNS after_IN treatment_NN with_IN SAHA_NNP [_NN
        43_CD ]_NN ._. As_IN SAHA_NNP treatment_NN increased_VBD histone_NN (_( H_NNP 3_CD and_CC H_NNP 4_LS )_)
        protein_NN and_CC acetylation_NN levels_NNS in_IN both_DT cell_NN lines_NNS ,_, this_DT may_MD
        have_VB altered_VBN the_DT association_NN of_IN histones_NNS with_IN DNA_NNP ,_, thereby_RB
        altering_VBG nucleosomal_NN conformation_NN and_CC stability_NN [_NN 27_CD ,_, 44_CD ]_NN ._.
        Local_JJ perturbations_NNS of_IN chromatin_NN structure_NN can_MD specifically_RB
        affect_VB the_DT accessibility_NN and_CC /_NN or_CC function_NN of_IN transcriptional_NN
        regulatory_JJ proteins_NNS that_WDT bind_NN DNA_NNP sequences_NNS in_IN the_DT region_NN
        where_WRB histone_NN acetylation_NN or_CC deacetylation_NN took_VBD place_NN [_NN
        44_CD ]_NN ._. HDAC_NNP inhibitors_NNS ,_, such_JJ as_IN trichostatin_NN A_DT and_CC trapoxin_NN ,_,
        modulate_VBP gene_NN expression_NN in_IN either_DT a_DT positive_JJ ,_, negative_JJ or_CC
        neutral_JJ fashion_NN [_NN 45_CD ]_NN ._. Ample_NNP studies_NNS have_VBP demonstrated_VBN the_DT
        implication_NN of_IN histone_NN hyperacetylation_NN in_IN gene_NN
        transcription_NN but_CC also_RB in_IN silencing_VBG gene_NN expression_NN of_IN
        others_NNS [_NN 27_CD ,_, 44_CD ,_, 45_CD ]_NN ._.
        It_PRP is_VBZ well_RB known_VBN that_IN E_NNP 2_CD F-_NNP 1_CD regulates_VBZ transcription_NN of_IN
        genes_NNS predominantly_RB expressed_VBD during_IN the_DT G_NNP 1_CD →_NN S_NNP transition_NN
        such_JJ as_IN cyclins_NNS [_NN 1_CD ,_, 5_CD ]_NN ,_, cdks_NNS [_NN 1_CD ]_NN ,_, 
        E_NNP 2_CD F-_NNP 1_CD gene_NN [_NN 46_CD ]_NN ,_, the_DT 
        RB_NNP 1_CD tumor_NN suppressor_NN gene_NN [_NN 8_CD ,_, 47_CD ]_NN ,_,
        and_CC genes_NNS for_IN DNA_NNP replication_NN and_CC repair_NN enzymes_NNS and_CC
        factors_NNS [_NN 4_CD ]_NN ._. It_PRP appears_VBZ that_IN SAHA_NNP has_VBZ a_DT profound_JJ
        inhibitory_NN impact_NN on_IN the_DT protein_NN levels_NNS of_IN key_JJ molecules_NNS ,_,
        E_NNP 2_CD F-_NNP 1_CD ,_, PCNA_NNP and_CC p_NN 21_CD ,_, essential_JJ for_IN DNA_NNP synthesis_NN ._. Based_VBN on_IN
        previous_JJ reports_NNS ,_, disintegration_NN of_IN the_DT cyclin_NN /_NN cdk_NN
        complexes_NNS important_JJ for_IN DNA_NNP synthesis_NN is_VBZ correlated_JJ to_TO
        E_NNP 2_CD F-_NNP 1_CD expression_NN level_NN [_NN 1_CD ,_, 5_CD ]_NN ._. It_PRP is_VBZ thus_RB conceivable_JJ to_TO
        interpret_VB that_IN the_DT profound_JJ inhibition_NN in_IN E_NNP 2_CD F-_NNP 1_CD and_CC PCNA_NNP
        protein_NN levels_NNS after_IN 24_CD h_NN of_IN exposure_NN to_TO 2_CD ._. 5_CD μM_NN SAHA_NNP may_MD
        result_VB in_IN disintegration_NN and_CC deactivation_NN of_IN D_NNP 1_CD ,_, E_NNP and_CC A_DT
        cdk_NN 2_CD complexes_NNS ,_, which_WDT consequently_RB leads_VBZ to_TO
        hypophosphorylation_NN of_IN the_DT three_CD Rb_NNP pocket_NN proteins_NNS ._. It_PRP is_VBZ
        plausible_JJ to_TO suggest_VB that_IN the_DT inhibition_NN in_IN E_NNP 2_CD F-_NNP 1_CD protein_NN
        levels_NNS by_IN SAHA_NNP was_VBD either_CC at_IN the_DT transcription_NN level_NN or_CC
        induction_NN of_IN the_DT ubiquitin-protein_JJ ligase_NN responsible_JJ for_IN
        E_NNP 2_CD F-_NNP 1_CD degradation_NN ,_, but_CC not_RB E_NNP 2_CD F-_NNP 4_CD ,_, and_CC this_DT resulted_VBD in_IN
        blocked_VBN DNA_NNP synthesis_NN ._. Further_RB work_NN is_VBZ necessary_JJ to_TO prove_VB
        whether_IN the_DT effect_NN of_IN SAHA_NNP is_VBZ at_IN the_DT RNA_NNP transcription_NN
        level_NN or_CC on_IN stability_NN of_IN E_NNP 2_CD F-_NNP 1_CD protein_NN ._.
        The_DT inhibition_NN in_IN nuclear_JJ p_NN 21_CD in_IN SAHA_NNP treated_VBD TM_NNP 2_CD H_NNP as_RB
        well_RB as_IN TM_NNP 10_CD cells_NNS underscores_VBZ that_IN SAHA-arrested_NNP cell_NN
        growth_NN is_VBZ through_IN a_DT p_NN 53_CD -_: independent_JJ pathway_NN ._. A_DT recent_JJ
        report_NN indicated_VBD that_IN the_DT transcription_NN of_IN p_NN 21_CD Cip_NNP 1_CD and_CC
        accumulation_NN of_IN acetylated_JJ histones_NNS associated_VBN with_IN the_DT
        promoter_NN and_CC coding_VBG regions_NNS of_IN that_DT gene_NN were_VBD induced_VBN after_IN
        2_CD h_NN in_IN 7_CD ._. 5_CD μM_NN SAHA_NNP and_CC fall_NN by_IN 24_CD h_NN in_IN T_NN 24_CD bladder_NN
        carcinoma_NN cells_NNS [_NN 48_CD ]_NN ._. Although_IN we_PRP have_VBP utilized_JJ 2_CD ._. 5_CD μM_NN
        SAHA_NNP ,_, our_PRP$ results_NNS are_VBP in_IN agreement_NN with_IN their_PRP$ data_NNS on_IN the_DT
        fall_NN in_IN p_NN 21_CD level_NN after_IN 24_CD h_NN of_IN treatment_NN ._.
        A_DT more_RBR intriguing_JJ and_CC novel_NN mechanism_NN of_IN SAHA-mediated_NNP
        cell_NN growth_NN arrest_NN was_VBD the_DT enhanced_JJ interaction_NN and_CC nuclear_JJ
        localization_NN of_IN Rb_NNP 2_CD /_NN p_NN 130_CD -_: E_NNP 2_CD F-_NNP 4_CD complexes_NNS in_IN both_DT cell_NN lines_NNS
        after_IN 24_CD h_NN of_IN treatment_NN ._. It_PRP is_VBZ well_RB documented_VBN that_IN E_NNP 2_CD F-_NNP 1_CD
        possesses_VBZ an_DT intrinsic_JJ nuclear_JJ localization_NN signal_NN whereas_IN
        E_NNP 2_CD F-_NNP 4_CD is_VBZ devoid_JJ of_IN such_JJ signal_NN [_NN 49_CD ,_, 50_CD ]_NN ,_, and_CC that_IN the_DT
        mechanism_NN of_IN E_NNP 2_CD F-_NNP 4_CD nuclear_JJ localization_NN has_VBZ been_VBN documented_VBN
        to_TO be_VB through_IN its_PRP$ interaction_NN with_IN Rb_NNP 2_CD /_NN p_NN 130_CD pocket_NN protein_NN ,_,
        which_WDT impedes_VBZ cell_NN cycle_NN progression_NN [_NN 39_CD ,_, 40_CD ]_NN ._.
        Furthermore_RB ,_, recent_JJ studies_NNS demonstrated_VBN that_IN Rb_NNP 2_CD /_NN p_NN 130_CD in_IN
        complexes_NNS with_IN E_NNP 2_CD F-_NNP 4_CD actively_RB represses_NNS E_NNP 2_CD F-_NNP 1_CD transcription_NN
        in_IN cell_NN differentiation_NN and_CC growth_NN arrest_NN ,_, and_CC that_IN this_DT
        complex_NN was_VBD considered_VBN the_DT main_JJ E_NNP 2_CD F-_NNP 1_CD regulator_NN during_IN the_DT
        early_JJ G_NNP 1_CD phase_NN [_NN 39_CD ,_, 51_CD ,_, 52_CD ]_NN ._. Other_JJ reports_NNS suggest_VBP that_IN Rb_NNP
        recruitment_NN of_IN HDAC_NNP 1_CD activity_NN repressed_JJ E_NNP 2_CD F-_NNP 1_CD [_NN 12_CD ,_, 13_CD ]_NN ._.
        Although_IN SAHA_NNP increases_NNS acetylation_NN of_IN histones_NNS H_NNP 3_CD and_CC H_NNP 4_CD ,_,
        it_PRP is_VBZ not_RB known_VBN whether_IN SAHA_NNP is_VBZ able_JJ to_TO inhibit_VB all_DT HDAC_NNP
        activities_NNS of_IN all_DT types_NNS of_IN histones_NNS ,_, including_VBG HDAC_NNP 1_CD ,_, or_CC
        whether_IN the_DT profound_JJ increase_NN in_IN Rb_NNP 2_CD /_NN p_NN 130_CD -_: E_NNP 2_CD F-_NNP 4_CD nuclear_JJ
        complex_NN after_IN SAHA_NNP treatment_NN may_MD have_VB an_DT alternative_JJ
        pathway_NN other_JJ than_IN recruitment_NN of_IN HDAC_NNP 1_CD activity_NN ._.
        The_DT difference_NN between_IN TM_NNP 10_CD (_( p_NN 53_CD wt_NN )_) and_CC TM_NNP 2_CD H_NNP (_( p_NN 53_CD null_NN )_)
        cell_NN cultures_NNS in_IN response_NN to_TO removing_VBG 2_CD ._. 5_CD μM_NN SAHA_NNP following_VBG
        2_CD or_CC 3_CD days_NNS of_IN treatment_NN was_VBD significant_JJ ._. We_PRP suggest_VBP that_IN
        it_PRP might_MD reflect_VB their_PRP$ difference_NN in_IN p_NN 53_CD status_NN ._. The_DT TM_NNP 10_CD
        cells_NNS did_VBD not_RB exhibit_VB signs_NNS of_IN cell_NN proliferation_NN or_CC
        '_POS recovery_NN '_'' during_IN the_DT following_JJ 3_CD -_: 4_CD days_NNS ._. TM_NNP 2_CD H_NNP cells_NNS ,_, in_IN
        contrast_NN ,_, recovered_VBN by_IN 88_CD %_NN after_IN 2_CD days_NNS of_IN treatment_NN ._.
        Longer_JJR treatment_NN may_MD be_VB necessary_JJ to_TO inhibit_VB TM_NNP 2_CD H_NNP (_( p_NN 53_CD
        null_NN )_) mammary_JJ epithelial_NN cells_NNS as_IN preliminary_JJ results_NNS
        indicate_VBP TM_NNP 2_CD H_NNP cells_NNS did_VBD not_RB recover_VB after_IN 3_CD days_NNS of_IN SAHA_NNP
        treatment_NN (_( data_NNS not_RB shown_VBN )_) ._. We_PRP suggest_VBP that_IN the_DT difference_NN
        in_IN growth_NN recovery_NN between_IN TM_NNP 10_CD (_( p_NN 53_CD wt_NN )_) and_CC TM_NNP 2_CD H_NNP (_( p_NN 53_CD
        null_NN )_) cell_NN lines_NNS after_IN 2_CD days_NNS in_IN 2_CD ._. 5_CD μM_NN SAHA_NNP may_MD be_VB
        attributed_VBN to_TO two_CD factors_NNS ,_, both_DT related_VBN to_TO their_PRP$ p_NN 53_CD
        status_NN ._. Firstly_NNP ,_, the_DT p_NN 53_CD in_IN TM_NNP 10_CD (_( p_NN 53_CD wt_NN )_) cells_NNS might_MD have_VB
        been_VBN acetylated_JJ upon_IN treatment_NN with_IN 2_CD ._. 5_CD μM_NN SAHA_NNP for_IN 2_CD or_CC 3_CD
        days_NNS ._. Recent_JJ studies_NNS demonstrated_VBD acetylation_NN of_IN p_NN 53_CD in_IN the_DT
        C-_NNP terminal_NN domain_NN increased_VBD the_DT DNA-binding_NNP capacity_NN of_IN the_DT
        protein_NN [_NN 53_CD ,_, 54_CD ,_, 55_CD ]_NN ._. This_DT event_NN is_VBZ obviously_RB not_RB present_JJ
        in_IN TM_NNP 2_CD H_NNP (_( p_NN 53_CD null_NN )_) ._. Secondly_RB ,_, although_IN TM_NNP 10_CD cells_NNS (_( p_NN 53_CD wt_NN )_)
        have_VBP lost_VBN 64_CD %_NN of_IN their_PRP$ nuclear_JJ p_NN 21_CD during_IN SAHA_NNP treatment_NN ,_,
        the_DT remaining_VBG 36_CD %_NN of_IN the_DT nuclear_JJ p_NN 21_CD plus_CC the_DT continued_VBN
        synthesis_NN of_IN p_NN 21_CD by_IN p_NN 53_CD activity_NN [_NN 55_CD ,_, 56_CD ,_, 57_CD ]_NN during_IN the_DT
        recovery_NN period_NN would_MD maintain_VB TM_NNP 10_CD cells_NNS in_IN the_DT inhibited_VBD
        state_NN for_IN several_JJ days_NNS without_IN SAHA_NNP ._. TM_NNP 2_CD H_NNP cells_NNS (_( p_NN 53_CD null_NN )_) ,_,
        in_IN contrast_NN ,_, lack_NN both_DT negative_JJ regulatory_JJ potentials_NNS of_IN
        acetylated_JJ p_NN 53_CD and_CC the_DT availability_NN of_IN nuclear_JJ p_NN 21_CD ._.
        We_PRP conclude_VBP that_IN the_DT mechanisms_NNS of_IN SAHA_NNP inhibition_NN of_IN
        DNA_NNP synthesis_NN and_CC cell_NN growth_NN arrest_NN at_IN G_NNP 1_CD were_VBD similar_JJ in_IN
        both_DT TM_NNP 10_CD (_( p_NN 53_CD wt_NN )_) and_CC TM_NNP 2_CD H_NNP (_( p_NN 53_CD null_NN )_) mouse_NN mammary_JJ
        epithelial_NN cell_NN lines_NNS ._. A_DT proposed_VBN mechanism_NN of_IN SAHA_NNP
        stresses_VBZ the_DT involvement_NN of_IN pRb_NN 2_CD /_NN p_NN 130_CD -_: E_NNP 2_CD F-_NNP 4_CD interaction_NN and_CC
        nuclear_JJ localization_NN ,_, which_WDT ultimately_RB results_VBZ in_IN cell_NN
        growth_NN arrest_NN and_CC repression_NN in_IN nuclear_JJ E_NNP 2_CD F-_NNP 1_CD and_CC PCNA_NNP
        protein_NN levels_NNS ,_, and_CC the_DT subsequent_JJ inhibition_NN of_IN DNA_NNP
        synthesis_NN in_IN both_DT cell_NN lines_NNS ._. However_RB ,_, p_NN 53_CD status_NN was_VBD
        critical_JJ in_IN maintaining_VBG growth_NN arrest_NN in_IN TM_NNP 10_CD cells_NNS 4_CD days_NNS
        after_IN removing_VBG SAHA_NNP treatment_NN ,_, whereas_IN TM_NNP 2_CD H_NNP cells_NNS (_( p_NN 53_CD
        null_NN )_) recovered_VBD growth_NN arrest_NN under_IN the_DT same_JJ conditions_NNS ._. We_PRP
        therefore_RB suggest_VBP that_IN the_DT dose_NN and_CC time_NN regimen_NN for_IN
        histone_NN deacetylase_NN inhibitors_NNS ,_, such_JJ as_IN SAHA_NNP ,_, may_MD have_VB to_TO
        consider_VB the_DT p_NN 53_CD status_NN of_IN breast_NN cancers_NNS ._.
      
      
        Abbreviations_NNP
        CI_NNP =_SYM confidence_NN interval_NN ;_: GPRD_NNP =_SYM General_NNP Practice_NNP
        Research_NNP Database_NNP ;_: NA-NSAID_NNP =_SYM nonaspirin_NN nonsteroidal_NN
        anti-inflammatory_JJ drug_NN ;_: RR_NNP =_SYM relativerisk_NN ;_: UGIC_NNP =_SYM upper_JJ
        gastrointestinal_NN complications_NNS ._. CI_NNP =_SYM confidence_NN interval_NN ;_:
        GPRD_NNP =_SYM General_NNP Practice_NNP Research_NNP Database_NNP ;_: NA-NSAID_NNP =_SYM
        nonaspirin_NN nonsteroidal_NN anti-inflammatory_JJ drug_NN ;_: RR_NNP =_SYM
        relativerisk_NN ;_: UGIC_NNP =_SYM upper_JJ gastrointestinal_NN
        complications_NNS ._.
      
    
  
